# FDA Approves Lumvoa (veligrotug) for Thyroid Eye Disease

> fda · REPORTED · 2026-06-30

Viridian Therapeutics received U.S. FDA approval for Lumvoa (veligrotug-vvze) for the treatment of thyroid eye disease, entering a market previously addressed only by Horizon Therapeutics' Tepezza and representing a major commercial milestone for the company.

About Viridian Therapeutics: Viridian Therapeutics is a clinical-stage biotech developing precision antibody therapies for thyroid eye disease and other serious ophthalmologic and autoimmune conditions.

- Company: Viridian Therapeutics
- Sector: therapeutics
- Primary source: https://www.stocktitan.net/news/fda-approvals.html

---
Source: MedFuel Intel news monitor. Verification tier: REPORTED. Informational only, not investment advice. Corrections: media@medfuelinc.com.